Home
Investments in the US
Summary of CNBC "Mad Money" Episodes

Mad Money: Key points from January 9, 2024 (Tuesday) Episode

Home › Forums › Investments in the US › Summary of CNBC “Mad Money” Episodes › Mad Money: Key points from January 9, 2024 (Tuesday) Episode

  • This topic is empty.
Viewing 0 reply threads
  • Author
    Posts
    • 2024-01-09 at 9:35 PM #7659
      暮眞★潤 (Jun Kurema)
      Keymaster

      This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Tuesday, January 9, 2024.  It also contains links to CNBC sites which contain video clips and transcripts.

       

      (1) Cramer says today’s market is more interested in AI technology for advertising, not health-care solutions (https://www.cnbc.com/2024/01/09/cramer-market-likes-ai-technology-for-advertising-not-health-care.html)

      • CNBC’s Jim Cramer on Tuesday marveled at the myriad of uses for generative artificial intelligence in health care, but concluded that Wall Street is more concerned with using that new technology for advertising.
      • “Could targeting the right consumer really be more important than saving the consumer’s life?” Cramer asked. “No, of course not. But investing is rarely about what’s important in a human sense, it’s about making money. And right now, analyzing data more efficiently for targeted ads is worth more than analyzing the data to figure out how to get people to live longer, healthier lives.”

      Ticker: NVDA, AMZN

       

      (2) [No Video Clip for non-Club Member] Executive Interview:Pfizer CEO Albert Bourla goes one-on-one with Jim Cramer (https://www.cnbc.com/video/2024/01/09/pfizer-ceo-albert-bourla-goes-one-on-one-with-jim-cramer.html)

      Pfizer CEO Albert Bourla joins ‘Mad Money’ host Jim Cramer at the JPMorgan healthcare conference to talk its cancer fighting efforts, vaccine sales and more.

      Ticker: PFE

       

      (3) Executive Interview: CVS CEO touts expanding primary care health services after major acquisitions (https://www.cnbc.com/2024/01/09/cvs-ceo-touts-primary-care-health-services-after-major-acquisitions.html)

      • In a Tuesday interview with CNBC’s Jim Cramer, CVS CEO Karen Lynch discussed her company’s expanding health services, saying primary care is an important part of the market.
      • In 2023, CVS closed two multibillion-dollar deals, acquiring home health service Signify and Oak Street Health, which focuses on providing primary care for seniors

      Ticker: CVS

       

      (4) Executive Interview: Regeneron CEO says the next big thing for biotech isn’t AI, it’s gene therapy (https://www.cnbc.com/2024/01/09/regeneron-ceo-says-gene-therapy-is-the-next-big-thing-for-biotech.html)

      • Regeneron CEO Leonard Schleifer elaborated on the biotech company’s newest ventures with CNBC’s Jim Cramer and pointed to gene therapy as especially innovative.
      • Schleifer suggested that “associating genes with disease” is going to drive the entire pharmaceutical industry.

      Ticker: REGN

       

      (5) Cramer’s Lighting Round: ‘Hold onto’ MP Materials (https://www.cnbc.com/2024/01/09/cramers-lighting-round-hold-onto-mp-materials.html)

      • Topgolf: “I like Topgolf…I think it’s an interesting good stock. I think at $14, you should be a buyer.”
      • MP Materials: “I would hold onto it. I don’t have a catalyst to buy it right now, but it is very, very low.”
      • Howmet Aerospace: “I like that call…What a stock Howmet is.”
      • Toast: ”…We got to see them make money. If they made money, then I am on board. Not until then.”
      • TransDigm Group: “I’ve got to tell you, I think you know the company better than me. But everything you said I understand to be true, and I think it is a terrific company…It’s one of those companies they should split their stock ten for one. And then I would be able to recommend it.”

      Ticker: MODG [I like it], MP [hold, no catalysts to buy now], HWN [I like the call (=buy)], TOST, TDG

       

      (6) Executive Interview: Abbott CEO Robert Ford: We had two objectives during COVID, help society and make company stronger (https://www.cnbc.com/video/2024/01/09/abbott-ceo-robert-ford-we-had-two-objectives-during-covid-help-society-and-make-company-stronger.html)

      Abbott CEO Robert Ford joins ‘Mad Money’ host Jim Cramer to talk lessons learned from the pandemic, quarterly earnings, weight loss drugs and more.

       

      Other Stocks Discussed (Calls with Audiences): Boeing (BA) [remain bull, unless you come up with 3rd manufacture besides BA and Airbus], Northrop Grumman (NOC) [you are right to pull the trigger], Hasbro (HAS) [hard stock to own]

       

      Ref: Links to other sites that relate to episode of January 9, 2024

      Disclaimer

      ****************************

      Previous episode Next Episode

       

  • Author
    Posts
Viewing 0 reply threads
  • The topic ‘Mad Money: Key points from January 9, 2024 (Tuesday) Episode’ is closed to new replies.